Last reviewed · How we verify

Clustoid® Max Forte

Inmunotek S.L. · Phase 2 active Biologic

Clustoid® Max Forte is a Biologic drug developed by Inmunotek S.L.. It is currently in Phase 2 development for Allergic diseases or immunological disorders (specific indication not publicly confirmed).

Clustoid® Max Forte is an immunotherapeutic agent designed to modulate immune responses, likely through allergen immunotherapy or immune tolerance induction.

Clustoid® Max Forte is an immunotherapeutic agent designed to modulate immune responses, likely through allergen immunotherapy or immune tolerance induction. Used for Allergic diseases or immunological disorders (specific indication not publicly confirmed).

At a glance

Generic nameClustoid® Max Forte
SponsorInmunotek S.L.
ModalityBiologic
Therapeutic areaImmunology
PhasePhase 2

Mechanism of action

Based on Inmunotek's focus on immunotherapy and the product name, this agent likely works by inducing immune tolerance or modulating T-cell and B-cell responses to specific allergens or antigens. The mechanism may involve shifting immune responses from Th2 (allergic) to Th1 or regulatory T-cell (Treg) pathways, thereby reducing allergic or autoimmune reactions.

Approved indications

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Clustoid® Max Forte

What is Clustoid® Max Forte?

Clustoid® Max Forte is a Biologic drug developed by Inmunotek S.L., indicated for Allergic diseases or immunological disorders (specific indication not publicly confirmed).

How does Clustoid® Max Forte work?

Clustoid® Max Forte is an immunotherapeutic agent designed to modulate immune responses, likely through allergen immunotherapy or immune tolerance induction.

What is Clustoid® Max Forte used for?

Clustoid® Max Forte is indicated for Allergic diseases or immunological disorders (specific indication not publicly confirmed).

Who makes Clustoid® Max Forte?

Clustoid® Max Forte is developed by Inmunotek S.L. (see full Inmunotek S.L. pipeline at /company/inmunotek-s-l).

What development phase is Clustoid® Max Forte in?

Clustoid® Max Forte is in Phase 2.

Related